Vesicular transmitter release can be regulated by transmittergated ion channels at presynaptic axon terminals. The central inhibitory transmitter GABA acts on such presynaptic ionotropic receptors in various cells, including inhibitory interneurons. Here we report that GABA-mediated postsynaptic inhibitory currents in CA3 pyramidal cells of rat hippocampal slices are suppressed by agonists of GABA A receptors. The e¡ect is present for both stimulus-induced and miniature IPSCs, indicating a reduction in the probability of vesicular release by presynaptic, action-potential-independent mechanisms. We conclude that the release of GABA from hippocampal CA3 interneurons is regulated by a negative feedback via presynaptic ionotropic GABA autoreceptors.
INTRODUCTION
The release of neurotransmitters from presynaptic boutons is regulated by a variety of mechanisms, including presynaptic autoreceptors which mostly mediate a negative feedback on transmitter release. It is well established that the central inhibitory transmitter GABA exerts such a negative feedback via presynaptic metabotropic GABA B autoreceptors. There is evidence, however, that GABA can also activate ionotropic autoreceptors in the mammalian spinal cord [1] , retina [2] , cerebellum [3] and in cultured hippocampal interneurons [4] . Recently, Ruiz and co-workers [5] have found that activation of GABA A receptors reduces action potential propagation and Ca 2 + entry at mossy fiber terminals.
The increasing number of descriptions of presynaptic ionotropic receptors makes it likely that these ligand-gated ion channels play an important role in the regulation of transmitter release and in presynaptic mechanisms of plasticity [6] . Their activation is likely to depend on the amount of transmitter released. Consistent with this idea, several recent studies have reported that changes in presynaptic GABA content cause alterations of the actionpotential-dependent and -independent release of GABA. These changes implicate a negative [5, 7, 8] or positive [9] [10] [11] correlation between presynaptic GABA content and vesicular release of GABA. Indeed, GABA can yield opposite effects on transmitter release at different synapses, i.e. facilitation [12] or depression [1, 5, 13] . The direction of the modulation depends on presynaptic factors, including the axonal membrane chloride gradient [12] and the activation of voltage-dependent ion channels at the presynaptic terminal [14] .
In order to evaluate whether presynaptic ionotropic GABA receptors do influence GABA release from hippocampal interneurons, we have applied GABA A receptor agonists to juvenile rat hippocampal slices. We measured evoked and spontaneous (miniature) inhibitory postsynaptic currents from CA3 pyramidal neurons. Activation of GABA A receptors clearly reduced action-potential-dependent and -independent GABA release indicating that GABA mediates a negative feedback on its own release via presynaptic ionotropic GABA receptors at hippocampal interneurons.
MATERIALS AND METHODS
Horizontal slices (200 mm) were obtained from 9-to 14-dayold Wistar rats as described elsewhere [15] (procedures approved by Local Government authorities). Whole-cell patch clamp recordings were performed at room temperature (20-251C) using an EPC-7 amplifier (List Medical, Darmstadt, Germany) and an upright microscope equipped with DIC. Input and series resistances were regularly controlled throughout the experiment and cells were excluded if they showed significant (4 50%) resealing or parallel decreases in synaptic current amplitude and series conductance. Intracellular solution contained (mM): CsCl 140, MgCl 2 
RESULTS
First, we tested whether tonic activation of GABA A receptors had any affect on action-potential-driven vesicular release of GABA. We measured stimulus-evoked IPSCs in CA3 pyramidal cells in the presence of antagonists for glutamate-and GABA B -receptors. The recording electrode contained 5 mM QX 314 to block Na + currents in the postsynaptic cell. Using symmetrical chloride conditions at À60 mV holding potential, inwardly directed IPSCs were elicited by B75% of the stimulations, i.e. failure rate was 25% (n ¼ 9 cells). We then applied muscimol (1 mmol) for 1 min via bath perfusion. Baseline noise was strongly increased in the presence of the drug and decreased to control values after 2-3 min of washout (see Fig. 2f ). Subsequently (starting 5 min after returning to ACSF perfusion), we recorded a second series of stimulus-induced IPSCs. In this situation, failure rate was significantly increased (p o 0.01; Wilcoxon test) and the mean amplitude of the remaining stimulus-evoked IPSCs decreased from 123 7 29 pA (control) to 49 7 15 pA (p o 0.05; Fig. 1 ; amplitudes averaged excluding failures). This effect might be caused by several different mechanisms: (1) suppression of vesicle release from presynaptic terminals; (2) shunt of action potential propagation in the presynaptic axon; (3) desensitization of postsynaptic receptors. Subsequent experiments strongly supported the first hypothesis.
If the effect of muscimol on IPSCs was exclusively due to action potential shunting, it should not be observed in recordings of miniature IPSCs (mIPSCs) in the presence of the sodium-channel blocker TTX. We therefore sampled spontaneous mIPSCs before and after application of muscimol (1 mM) for 1 min. As expected, baseline noise was transiently increased by the GABA A receptor agonist (Fig. 2a,f) and input resistance decreased to 47 7 15% of baseline values (n ¼ 12; p o 0.01). The increased baseline noise was sensitive to the GABA A receptor antagonist bicuculline (n ¼ 2). In order to control for potential effects of these impaired recording conditions on the measurement or detection of mIPSCs, we recorded both immediately after application of muscimol (musc + 1 0 ) and B5 min later (musc + 5 0 ). At this later time, muscimol had been washed out as indicated by the recovery of baseline noise ( detailed comparison of mIPSC amplitude distributions before and after application of muscimol (musc + 5 0 ) revealed no change in 3 cells, a shift towards lower amplitudes in 4 cells and a shift towards larger amplitudes in 1 cell. Regardless of these differences, the frequency of mIPSCs decreased after application of muscimol in all cells. The stability of our recording conditions over 4 1 h was independently tested in 3 cells which were recorded without addition of muscimol (Fig. 2c) . These data do not indicate significant rundown effects on amplitude or frequency of mIPSCs.
As an additional test for desensitization, we activated GABA A receptors by local (pressure) application of GABA (100 mmol) to the somatic membrane of CA3 pyramids. The amplitude of the evoked current was similar before exposure to 1 mM muscimol (3.5 7 0.8 nA) and 5 min after muscimol treatment and wash (musc + 5 0 ; 2.9 7 0.6 nA) indicating that postsynaptic GABA A receptors are fully functional 5 min after application of muscimol ( Fig. 3 ; n ¼ 5; p 4 0.05).
In order to ensure that the observed effects of muscimol are specifically mediated by GABA A receptors, we repeated the experiments with a different GABA A receptor agonist, isoguvacine (10 mM). The effects of isoguvacine were more easily reversible than those of muscimol, and therefore the substance was bath-applied for 10 min and mIPSCs were measured at the end of this period in the presence of the drug. Consistent with the action of muscimol, the frequency of mIPSCs was significantly reduced from 106.2 7 40.8 events/min to 33 7 28.7 events/min ( Fig. 4a-c ; n ¼ 5; p o 0.05). Miniature IPSC amplitudes (Fig. 4d) were not affected by the drug (p 4 0.4); amplitude distributions ( GABA receptors? One important consequence may be that vesicular GABA release from terminals of inhibitory interneurons is suppressed when the local concentration of the transmitter increases. This mechanism might explain the paradoxical reduction in mIPSC frequency upon increasing the neuronal GABA content [7, 8 (see also discussion)]. We therefore controlled for the effect of the [GABA]-enhancing drug vigabatrin on mIPSCs. Incubation with 100 mM vigabatrin for 3-9 h (mean 6 h 22 min) dramatically decreased the frequency of mIPSCs from 103.5 7 34.0 to 7.2 7 1.4 events/min ( Fig. 5a ; n ¼ 9 cells with vigabatrin, n ¼ 5 control cells, p o 0.01, Wilcoxon-test) with a slight, but not significant, reduction of mIPSC amplitude (Fig. 5b,  p 4 0.05 ). This observation is well compatible with a negative feedback of presynaptic ionotropic GABA receptors on vesicular release of GABA, similar to the observations by Overstreet and Westbrook [7] and Wu et al. [8] .
DISCUSSION
Our results show that GABA negatively modulates its own release through presynaptic ionotropic GABA receptors on interneurons innervating CA3 pyramidal cells. The effect could be elicited with muscimol as well as with isoguvacine, favoring the existence of presynaptic GABA A rather than GABA C receptors [16] , consistent with recent observations by Ruiz et al. [5] at mossy fiber terminals and of Jang et al. [14] at glycinergic synapses on spinal cord neurons. Ligandgated ion channels occur at many axon terminals [6] , and may play a major role in short-term plasticity at excitatory synapses [17] . Ionotropic GABA receptors at mammalian axon terminals have been originally described by Eccles and co-workers [1] but are also present at various glycinergic [14] , glutamatergic [18] and GABAergic [2] [3] [4] terminals. Depending on the direction and amplitude of the presynaptic potential change, such presynaptic GABA receptors may trigger [17] or suppress [5] antidromic action potentials, and can facilitate [2] or suppress [1] transmitter release. Effects on voltage-gated ion channels at the presynaptic terminal may also lead to different effects on the frequency of mIPSCs and on action-potential-induced release [14] . In our hands, activation of GABA A receptors clearly reduced both action-potential-dependent and -independent vesicular release of GABA. The observed suppression of mIPSCs and the absence of significant postsynaptic GABA A receptor desensitization indicate a presynaptic localization of the effect. We cannot exclude the possibility that the GABAergic drugs might have impaired the function of presynaptic GABA-transporters [19] . This would result in an enhanced ambient GABA concentration and subsequently an enhanced GABA-mediated membrane conductance of the postsynaptic cells [15] . However, these conditions did not prevail in our musc + 5 0 protocol. Moreover, if muscimol had blocked GABA uptake, its effects on mIPSC frequency would still be mediated by presynaptic ionotropic GABA receptors. It should also be noted that in immature hippocampal tissue, GABA transporters are present at the somatic membranes of interneurons and travel towards the axon terminals after B2 weeks of postnatal development [20] . Thus, synaptic effects of GABA uptake on GABA concentration may be less pronounced in the immature tissue used in the present study.
While the precise mechanism of the presynaptic modulation is not yet known, our observations would be compatible with a hyperpolarization of the presynaptic axon terminal, indicating a chloride equilibrium potential negative from resting membrane potential. E Cl depends mostly on the activity of the chloride transporter KCC2 [21] , but we do not know of any data concerning the presynaptic distribution of this transporter. In a recent study, however, enhanced chloride loading of presynaptic neurons could indeed reverse the effects of (normally hyperpolarizing) presynaptic GABA A receptors [5] . In addition, we cannot exclude alternative mechanisms such as changes in presynaptic volume following GABA-induced ion fluxes. At present, however, we have no direct evidence for either mechanism.
The autoinhibition of GABA release within area CA3 may explain recent observations of reduced GABA release following an increase in intracellular and ambient GABA concentration after treatment with the GABA-transminase blocker vigabatrin [7, 8] . Similar to our present observations (Fig. 5) , vigabatrin suppressed both stimulus-evoked and miniature IPSCs. In a previous study, however, we had found an increased, rather than decreased, frequency of mIPSCs in cultured hippocampal slices after long-term incubation with vigabatrin [9] . Several different mechanisms may explain this apparent discrepancy: presynaptic GABA receptors may be differentially expressed in different preparations and, most importantly, chloride extrusion mechanisms may differ [21] . There are also several experimental differences between the work by Engel et al. [9] and our present approach, most notably the time of incubation. Indeed, the acute and long-term effects of vigabatrin may differ, causing even pro-convulsant effects of this anticonvulsant drug at early stages after application [22] .
The effects of muscimol on the failure rate of evoked IPSCs and on mIPSC frequency reversed slowly and incompletely after washout of the drug. Such long-lasting effects of muscimol have also been observed in other neuronal preparations [23] . It may be that presynaptic GABA receptors have a much higher affinity towards muscimol than postsynaptic receptors (where the effects were readily reversible). Alternatively, muscimol might induce long-lasting secondary effects, e.g. on the size of the readily releasable pool of vesicles. The effect of isoguvacine, on the other hand, was completely reversible after wash-out of the drug.
In summary, our data offer a new pathway for the regulation of GABA release by inhibitory interneurons in the hippocampus. The inhibition of GABA release is likely to be mediated by short, GABA A receptor-mediated IPSPs, which may then be followed by a longer-lasting GABA B receptor-mediated inhibition. This biphasic modulation of the probability of transmitter release may have profound effects on the timing of successive quantal release processes at individual synapses and, most interestingly, the effects may depend on the transmitter content of individual vesicles. Our observations may therefore explain recent observations from preparations with pharmacologically altered GABA levels and may be of significance for the pathophysiology and pharmacology of epilepsy. 
